TLR3 and neoplasm: Lipopolysaccharide-primed MSC1 showed a suppressive effect on proliferation, migration, and invasion of tumor cells and attenuated tumor growth and metastasis in mouse tumor models, whereas MSC2, primed with TLR3 agonist poly(I:C), had the opposite, tumor-supporting effects in these model systems [40].